Purigen Biosystems

Purigen Biosystems develops an isotachophoresis chip for nucleic acid preparation.

Purigen Biosystems, Inc. operates in the biotechnology sector. Purigen Biosystems, Inc. was incorporated in 2012 and is based in Alviso, California. Purigen Biosystems’ transformative platform provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. Purigen’s system is compatible with a range of samples including: mammalian cells, FFPE and FNA tissue biopsies, plasma, blood, and buccal swabs. Purigen is proudly affiliated with StartX Med, a Stanford-University-affiliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.